2 recruiting, 1 active not recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Active not recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Stephen Shiao: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation Pembrolizumab, Radiotherapy, Axatilimab - TNBC - Triple-Negative Breast Cancer, Breast Cancer | Phase 2 | Recruiting | Stephen Shiao | 34 | 2026-12-01 | 2026-11-16 |
| Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation Pembrolizumab, Radiation Therapy, Axatilimab - TNBC - Triple-Negative Breast Cancer, Breast Cancer | Phase 2 | Recruiting | Stephen Shiao | 35 | 2023-11-17 | 2026-11-16 |
| Breast Cancer Study of Preoperative Pembrolizumab + Radiation Pembrolizumab, RT Boost - Breast Cancer | Phase 1 / Phase 2 | Active not recruiting | Stephen Shiao | 66 | 2017-12-22 | 2026-04-20 |
Breast Neoplasms (3) · Triple Negative Breast Neoplasms (3)
pembrolizumab (3) · Radiotherapy (2) · axatilimab (2)
United States (3)